The PD-1/PD-L1 system reduces T lymphocyte proliferation, cytokine production, and cytotoxicity in cancer cells, causing fatigue and apoptosis of tumor-specific T cells and allowing cancer cells to dodge immune response [7]. The gene discussed is CD274; the disease is cancer.